Darrell Nelson Kotton MD
Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine
Professor, Pathology & Laboratory Medicine
670 Albany St

Sections
Pulmonary, Allergy, Sleep & Critical Care Medicine
Centers
Center for Regenerative Medicine
Pulmonary Center
Framingham Heart Study
Evans Center for Interdisciplinary Biomedical Research
Biography
Darrell N. Kotton, MD is the founding director of the Center for Regenerative Medicine of Boston University and Boston Medical Center. He is a physician-scientist with attending physician duties in pulmonary and critical care medicine at Boston Medical Center and is the David C. Seldin Professor in the department of medicine and in the department of pathology and laboratory medicine at the Boston University Chobanian and Avedesian School of Medicine. Dr. Kotton is an Allen Distinguished Investigator, a Paul G. Allen Frontiers Group advised program of the Paul G. Allen Family Foundation. He is also an elected member of the American Society of Clinical Investigators and the Association of American Physicians. He leads a basic research laboratory, funded continuously by the NIH since 2004, focused on lung regeneration and stem cell biology, and he serves on the NIH’s National Heart Lung and Blood Institute’s Board of External Experts. He is the recipient of the American Thoracic Society’s “Recognition Award for Scientific Accomplishments” (2018), the AAMC inaugural national “Research Resources Sharing Award” (2017), the Alpha-1 Foundation’s “Researcher of the Year” (2013) and “Shillelagh” (2010) Awards, Boston University’s Graduate Medical Sciences Educator of the Year Award (2018), and the Robert Dawes Evans Senior Research Mentor Award from Boston University.
Expertise: Stem Cell Biology; iPS cells; Reprogramming; Gene Therapy; Lung Developmental Biology.
Other Positions
Education
MD, Washington University School of Medicine, 1994
BA, University of Pennsylvania, 1989
Publications
Wang R, Simone-Roach C, Lindstrom-Vautrin J, Wang F, Rollins S, Bawa PS, Lu J, Tang Y, Beermann ML, Schlaeger T, Mahoney J, Rowe SM, Hawkins FJ, Kotton DN. De Novo Generation of Pulmonary Ionocytes from Normal and Cystic Fibrosis Human Induced Pluripotent Stem Cells. Am J Respir Crit Care Med. 2023 May 01; 207(9):1249-1253. PMID: 36857488.
Published on 4/15/2023Pradhan A, Che L, Ustiyan V, Reza AA, Pek NM, Zhang Y, Alber AB, Kalin TR, Wambach JA, Gu M, Kotton DN, Siefert ME, Ziady AG, Kalin TV, Kalinichenko VV. Novel FOXF1-Stabilizing Compound TanFe Stimulates Lung Angiogenesis in Alveolar Capillary Dysplasia. Am J Respir Crit Care Med. 2023 Apr 15; 207(8):1042-1054. PMID: 36480964.
Published on 2/1/2023Kee J, Thudium S, Renner DM, Glastad K, Palozola K, Zhang Z, Li Y, Lan Y, Cesare J, Poleshko A, Kiseleva AA, Truitt R, Cardenas-Diaz FL, Zhang X, Xie X, Kotton DN, Alysandratos KD, Epstein JA, Shi PY, Yang W, Morrisey E, Garcia BA, Berger SL, Weiss SR, Korb E. Author Correction: SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. Nature. 2023 Feb; 614(7949):E44. PMID: 36747034.
Published on 1/25/2023Yampolskaya M, Herriges M, Ikonomou L, Kotton D, Mehta P. scTOP: physics-inspired order parameters for cellular identification and visualization. bioRxiv. 2023 Jan 25. PMID: 36747864.
Published on 1/20/2023Burgess CL, Huang J, Bawa P, Alysandratos KD, Minakin K, Morley MP, Babu A, Villacorta-Martin C, Hinds A, Thapa BR, Wang F, Matschulat AM, Morrisey EE, Varelas X, Kotton DN. Generation of human alveolar epithelial type I cells from pluripotent stem cells. bioRxiv. 2023 Jan 20. PMID: 36711505.
Published on 1/11/2023Chen DY, Chin CV, Kenney D, Tavares AH, Khan N, Conway HL, Liu G, Choudhary MC, Gertje HP, O'Connell AK, Adams S, Kotton DN, Herrmann A, Ensser A, Connor JH, Bosmann M, Li JZ, Gack MU, Baker SC, Kirchdoerfer RN, Kataria Y, Crossland NA, Douam F, Saeed M. Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation. Nature. 2023 Mar; 615(7950):143-150. PMID: 36630998.
Published on 1/10/2023Alysandratos KD, Garcia-de-Alba C, Yao C, Pessina P, Huang J, Villacorta-Martin C, Hix OT, Minakin K, Burgess CL, Bawa P, Murthy A, Konda B, Beers MF, Stripp BR, Kim CF, Kotton DN. Culture impact on the transcriptomic programs of primary and iPSC-derived human alveolar type 2 cells. JCI Insight. 2023 Jan 10; 8(1). PMID: 36454643.
Published on 1/10/2023Chen DY, Kenney D, Chin CV, Tavares AH, Khan N, Conway HL, Liu G, Choudhary MC, Gertje HP, O'Connell AK, Kotton DN, Herrmann A, Ensser A, Connor JH, Bosmann M, Li JZ, Gack MU, Baker SC, Kirchdoerfer RN, Kataria Y, Crossland NA, Douam F, Saeed M. Role of spike in the pathogenic and antigenic behavior of SARS-CoV-2 BA.1 Omicron. bioRxiv. 2023 Jan 10. PMID: 36263066.
Published on 1/1/2023Kee J, Thudium S, Renner DM, Glastad K, Palozola K, Zhang Z, Li Y, Lan Y, Cesare J, Poleshko A, Kiseleva AA, Truitt R, Cardenas-Diaz FL, Zhang X, Xie X, Kotton DN, Alysandratos KD, Epstein JA, Shi PY, Yang W, Morrisey E, Garcia BA, Berger SL, Weiss SR, Korb E. Publisher Correction: SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. Nature. 2023 Jan; 613(7945):E5. PMID: 36624294.
Published on 12/7/2022Torchia JA, Tavares AH, Carstensen LS, Chen DY, Huang J, Xiao T, Mukherjee S, Reeves PM, Tu H, Sluder AE, Chen B, Kotton DN, Bowen RA, Saeed M, Poznansky MC, Freeman GJ. Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo. Sci Adv. 2022 Dec 09; 8(49):eabq6527. PMID: 36475798.
Media Mentions
Published on 2/9/2022
Ambitious Effort to Develop Lab-Grown Lungs Wins Paul G. Allen Frontiers Group Funding
Published on 9/23/2021
MED’s Biology of the Lung Funded through Its 50th—Yes, 50th—Year
Published on 9/1/2021
Modeling Inaccessible Cells from Induced Stem Cells Heralds Hope for Untreatable Lung Diseases
Published on 7/1/2021
BU awarded T32 grant to mentor research trainees in lung biology and pulmonary sciences
Published on 1/11/2021
How Coronavirus Damages Lung Cells within Mere Hours
Published on 12/22/2020
$2.4M NIH Grant Supports Boston Team Creating Cell Model for IPF
Published on 12/15/2020
CF Foundation Awards Research Projects to Advance Therapies for All CF Patients
Published on 9/28/2020
How Coronavirus Kickstarts Deadly Lung Inflammation
Published on 9/25/2020
Boston University Researchers Shed Light on How COVID Causes Fatal Lung Inflammation
Published on 9/24/2020
In Deadly COVID-19 Lung Inflammation, BU Researchers Discover a Culprit in NFkB Pathway
View full list of 16 media mentions.